Clinical Trials
5 trialsNCT06454383 2026-04-13
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT05443425 2025-07-04
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
City of Hope Medical Center
Phase 1 Recruiting
NCT04997993 2025-06-25
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase 1 Recruiting
NCT01611675 2017-04-06
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Massachusetts General Hospital
Phase 1 Terminated
NCT00001573 2008-03-04
A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed